8th International Conference on Autoimmunity: Mechanisms and Novel Treatments

Program

Sunday, September 17

     

6:00 PM

 

Conference Registration

     

8:00 PM

 

Welcome Reception and Dinner

     

Monday, September 18

     

8:00 AM

 

Breakfast

     

8:55 AM

 

Welcome and Opening Remarks

     

SESSION I

 

Basic mechanisms of immune function

Chairs: Melanie Greter and Daniel Campbell

9:00 AM

1

Circulating CD4+ T cells with unique functional properties that are related to epidermal Trm

Daniel Campbell, Iris Gratz, Maria Klicznik, Thomas Duhen, and Barbara Hoellbacher

9:30 AM

2

TGF-b and tissue macrophages

Xueyang Yu, Anne Buttgereit, Iva Lelios, Dilay Cansever, Burkhard Becher, and Melanie Greter

10:00 AM

3

Targeting targeted treatment in Lupus

George Tsokos

10:30 AM

4

Specialization of Tregs in Th1 responses

Katharina Littringer, Nikolas Rakebrandt, Xiaobei Zhou, Michelle Schorer, Tamas Dolowschiak, Mark Robinson, and Nicole Joller

     

10:45 AM

 

Coffee Break and Poster Session

     

SESSION II

 

Innate and adaptive control of autoimmunity

Chairs: Jessica Hamerman and Jeff Bluestone

11:15 AM

5

Manipulating Tregs to control tolerance in autoimmunity and cancer

Jeffrey Bluestone

11:45 AM

6

Dysregulated TLR7 signaling drives anemia via development of novel hemophagocytes

Holly Akilesh, Matthew Buechler, Jeffrey Duggan, William Hahn, Xizhang Sun, Griffin Gessay, Elizabeth Whalen, Michael Mason, Keith Elkon, Adam Lacy-Hulbert, Marion Pepper, and Jessica Hamerman

12:15 PM

7

Autoreactive T cells in narcoleptic patients

Federica Sallusto

12:45 PM

8

Butyrophilin (BTN) molecules control γδ T cells in tissue epithelia

David Rhodes, Neil McCarthy, and Matthias Eberl

1:00 PM

9

Ecoimmunity, self tolerance as a dynamic a predator prey equilibrium

Uri Nevo

     

1:15 PM

 

Lunch and Informal Discussions

     

7:30 PM

 

Dinner and Informal Discussions

     
         

Tuesday, September 19

     

8:00 AM

 

Breakfast

     

SESSION III

Immunoregulatory Mechanisms I

Chairs: Carola Vinuesa and Antonio Lanzavecchia

9:00 AM

10

Antibody diversification by somatic mutations and DNA transposition

Antonio Lanzavecchia

9:30 AM

11

Role of TFH-derived dopamine in human germinal centres

Ilenia Papa, David Saliba, Maurilio Ponzoni, Pablo Canete, Paula  Gonzalez-Figueroa, Sonia Bustamante, Salvatore Valvo, Rebecca Sweet, Michelle Grimbaldeston, Michael  Meyer-Hermann, Michael Dustin, Claudio Doglioni, and Carola Vinuesa

10:00 AM

12

Developing therapies based on Epstein-Barr virus’s ability to predispose for Multiple Sclerosis

Iryna Shanina, citlali Marquez, and Marc Horwitz

10:30 AM

13

IL-10 producing CCR6+T-cells are a distinct population of B-helper T-cells that play a pathogenic role in systemic lupus erythematosus

Federica Facciotti, Paola Larghi, Nicola Gagliani, Sergio Abrignani, Pierluigi Meroni, Richard Flavell, and Jens Geginat

     

10:45 AM

 

Coffee Break and Poster Session

SESSION IV

Immunoregulatory Mechanisms II

Chairs: Mark Travis and Shimon Sakaguchi

11:45 AM

14

TCR signaling, Treg, and autoimmunity

Shimon Sakaguchi

12:15 PM

15

Regulation of the intestinal immune response by integrins and TGF-beta

Mark Travis

12:45 PM

16

Unexpected role(s) for IRF5 risk variants in SLE disease onset

Betsy Barnes, Dan Li, Bharati Matta, and Su Song

1:00 PM

17

Publishing: Myths and legends

Zoltan Fehervari

     

1:30 PM

 

Lunch and Informal Discussions

     

7:30 PM

 

Dinner and Informal Discussions

     
       

Wednesday, September 20

     

8:00 AM

 

Breakfast

     

SESSION V

Targeting Autoimmunity

Chairs: Steve Miller and Sergio Lira

9:00 AM

18

Tolerogenic regulation of activated diabetogenic CD4+ and CD8+ T cells via Treg induction using antigen-associated PLG nanoparticles

Stephen Miller, Suchitra Prasad, Tobias Neef, Dan Xu, Joseph Podojil, Daniel Getts, and Lonnie Shea

9:30 AM

19

Regulation of CNS inflammation by astrocytes

Francisco Quintana

10:00 AM

20

Development of a novel animal model to study colitis

Sergio Lira

10:30 AM

21

Pancreatic nerve electrostimulation inhibits recent onset autoimmune diabetes

Philippe Blancou

     

10:45 AM

 

Coffee Break

     

SESSION VI

T cell function and dysfunction

Chairs: Lucy Walker and James Moon

11:15 AM

22

Tolerance in the self antigen-specific CD4+ T cell repertoire

James Moon, Francois Legoux, and Zimeng Zhang

11:45 AM

23

Regulation of Tregs in the central nervous system

Thomas Korn

12:15 PM

24

Understanding and manipulating Treg homeostasis

Lucy Walker

12:45 PM

25

Tissue-resident memory T cells as therapeutic targets

Simone Park, Susan Christo, Julia Prier, Clara Castellucci, Erica Wynne-Jones, Francis Carbone, Scott Mueller, and Laura Mackay

1:15 PM

26

Narcolepsy: selective autoimmune destruction of a subpopulation of sleep-regulating neurons

Raphaël Bernard-Valnet, Xuan-Hung Nguyen, Clémence Quériault, Lidia Yshii, Jan Bauer, Yves Dauvilliers, Christelle Peyron, and Roland Liblau

     

1:30 PM

 

Lunch and Informal Discussions

     

3:30 PM

 

City Tour

     

7:30 PM

 

Dinner and Informal Discussions

     

Thursday, September 21

     

8:00 AM

 

Breakfast

     

SESSION VII

Immune Tolerance I

Chairs: David Scott and Burkhard Becher

9:00 AM

27

Four shades of engineered regulatory T cells and killers

David Scott

9:30 AM

28

T-cell-derived GM-CSF mediates graft-vs-host disease but is dispensable for graft-vs-leukemia effect

Burkhard Becher

10:00 AM

29

Fate-mapping of GM-CSF in inflammation

Juliana Komuczki, Bettina Schreiner, Marija Banovic, Pawel Pelczar, and Burkhard Becher

10:15 AM

30

Apoptotic cell induced AhR activity is required for immunologic tolerance and suppression of lupus

Rahul Shinde, Kebria Hezaveh, Lara  Utsch, Andreas Kloetgen, Ankur  Chakravarthy, Tiago Da Silva Medina, Marie Jo Halaby, Reema Deol, Aristotelis Trisigos, David Munn, Michael Madaio, Zahi Touma, Joan Wither, Daniel De Carvalho, and Tracy McGaha

     

10:30 AM

 

Coffee Break and Poster Session

     

SESSION VIII

Immune Tolerance II

Chairs: Ari Waisman and Jen Gommerman

11:30 AM

31

Human dendritic cells: From development to functions

Florent Ginhoux

12:00 PM

32

Th17 and IL-17 in CNS diseases

Ari Waisman

12:30 PM

33

Recirculating intestinal IgA-producing cells regulate neuroinflammation

Jennifer Gommerman

1:00 PM

34

Thymus-derived Treg cell development is regulated by C-type-lectin–mediated BIC/miRNA155 expression

Raquel Sanchez-Diaz, Rafael Blanco-Dominguez, Katerina Tsilingiri, Beatriz Linillos-Pradillo, Hortensia  de la Fuente, Francisco Sanchez-Madrid, Maria L Toribio, Rinako  Nakawaga, and Pilar Martin

     

1:15 PM

 

Closing Remarks

     

1:20 PM

 

Lunch and Informal Discussions

     

8:00 PM

 

Farewell Dinner

     

Friday, September 22

     

8:00 AM

 

Breakfast

     

10:00 AM

 

Departure

       

POSTERS

35

Role of diabetes in the Etiology of Laryngeal cancer

Alexandre Didier and Roberto Menicagli

36

Sex-dependent treatment of chronic EAE with partial MHC class II constructs

Gil Benedek, Priya Chaudhary, Roberto Meza-Romero, Evan Calkins, Gail Kent, Halina Offner, Dennis Bourdette, and Arthur Vandenbark

37

Mining helminth secretions for new classes of immune suppressing drugs

Taylor Smallwood, Richard Clark, Jason Mulvenna, Johan Rosengren, and John Miles

38

Recombinant Fc hexamers show great potential for replacement of IVIG for treatment of autoimmune diseases

Bonnie Lewis, Donald Branch, Rolf Spirig, and Fabian Käsermann

39

Granzyme B in Autoimmune Skin Diseases: A Key Player in Reduced Barrier Function and Blistering

David Granville, Valverio Russo, Theo Klein, Darielle Lim, Nick Carr, Matthew Zeglinski, Richard Crawford, and Christopher Overall

40

The Lys63-deubiquitination of Smad7 by CYLD is required for T cell homeostasis and Smad-dependent TGF-β signaling

Yilang Tang, Sonja Reissig, and Ari Waisman

41

Increased number of GITR positive regulatory T cells by an anti-GITR antibody prevents diabetes in NOD mice

Luigi Cari, Pia Montanucci, Giuseppe Basta, Erika Ricci, Maria Petrillo, Jun Shimizu, Teresa Pescara, Riccardo Calafiore, Carlo Riccardi, and Giuseppe Nocentini

42

Therapeutic contribution of administration of coenzyme Q10, ω-3-polyunsaturated fatty acids and their mixture on skeletal muscle mitochondria functions and on the plasmatic level of γ-tocopherol studied in experimental arthritis

Katarína Bauerová, Jarmila Kucharská, Silvester Poništ, Lukáš Slovák, Ľudmila Pašková, Oľga Vančová, Danica Mihalová, and Anna Gvozdjáková

43

Targeting islet-specific CD8 T cells in Type 1 Diabetes

Dimitri  Kakabadse, Mark Lewis, Sigal  Fishman, Evy Leenheer, Joanne  Davies, Gidion Gross, and Susan Wong

44

Endocytic regulation of IL-17 cytokines in stromal cells

Cristina Ottone, Ash Maroof, Alex MacPherson, and Stevan Shaw

45

Sex differences in the effect of vitamin D on inflammatory heart disease: protective in women but damaging in men

Katelyn Bruno, Jessica Mathews, Leslie Cooper, Erika Douglass, Michael Coronado, and DeLisa Fairweather

46

Sex differences in soluble ST2 predict heart failure during myocarditis and DCM in patients and mice

Katelyn Bruno, Leslie Cooper, Michael  Coronado, Jessica Mathews, Anneliese Hill, Erika Douglass, and DeLisa Fairweather

47

Regulation of focal adhesion assembly and Lamellopodia Dynamics with WNT signaling ligands in Rheumatoid Arthritis

Aigul Sharip, Altynai Adilbayeva, Yergali Bexeitov, and Jeanette  Kunz

48

CD40-pathway activation in ectopic lymphoid structure (ELS)-resident B cells contributes to disease pathology in primary Sjögren’s syndrome

Grazyna Wieczorek, Marc Bigaud, Sabina Pfister, Sebastian  Hoersch, Katriona McMichael, Catherine Afatsawo, Meike Hamburger, Celine Texier, Celine Cojean, Maurane Henry, and James Rush

49

Learning SLE pathological mechanisms from multi 'omics profiles

Sabina Pfister, Nicholas Kelley, Thomas Schlitt, Anita  Fernandez, Marc Sultan, Maroof Hasan, Anis Mir, and James Rush

50

Role of the transcriptional silencer Ets-2 in the pathogenesis of autoimmune diseases 

Ioannis Panagoulias, Ioanna Aggeletopoulou, Panagiota Davoulou, Vily Panoutsakopoulou, and Athanasia Mouzaki

51

Treatment of dendritic cells with dexamethasone and MPLA induces a transcriptional profile that promotes regulation of immune responses

Juan Aguillon, Paulina Garcia-Gonzalez, Katina Schinnerling, Jaxaira Maggi, Lilian Soto, Oscar Neira, Ahmed Medhi, Hendrik Nel, Diego Catalan, Ricardo Verdugo, and Ranjeny Thomas

52

Intima-media tickness in patients with antiphospolipid sindrome in Bulagrian population.

Nikolay  Stoilov, Vladimira Boyadzhieva, Rasho Rashkov, and Stefan Stefanov

53

Multiple Sclerosis (MS): Nanoformulation of the biologic "LIF" to re-establish endogenous reparative homeostasis in the CNS

Su Metcalfe

54

The Foxo3/Eomes axis regulates CD4 T cell differentiation and susceptibility to autoimmunity

Michael Michieletto, caroline Stienne, and Anne Dejean

55

Extracellular hsa-miR-Chr8:96 as a unique biomarker for diagnosis of autoimmune myocarditis patients

Rafael Blanco-Dominguez, Raquel Sánchez-Díaz, Beatriz Linillos-Pradillo, Francisco Sánchez-Madrid, and Pilar Martin

56

Suppression of autoreactive T and B lymphocytes by selective therapy in humanized murine SCID models of autoimmunity

Silviya Bradyanova, Nikolina Mihaylova, Petroslav Chipinski, and Andrey Tchorbanov

57

T cell activation and differentiation

Antal Nagy, Douglas Pinheiro, Maria Klicznik, Gertrude Achatz, Iris Gratz, Raimund Holly, and Abul Abbas

58

Alleviation of Chronic Inflammation by a novel Ganoderic analogue via dual HO-1/Nrf-2 and NF-κB inhibitory pathway against Complete fruend’s adjuvant induced arthritis

Vikas Kumar and P Malairajan

59

Foxo1 inactivation is essential for effector T cell activation

Jenna Sullivan and Daniel Campbell

60

Helminth-derived extracellular vesicles - a novel therapeutic for inflammation? 

Gillian Coakley, Jana McCaskill, Jessica Borger, Fabio Simbari, Henry McSorley, Amy Buck, and Rick Maizels

61

Acute exposure of green synthesized ZnO nanoparticles of Prosopis cineraria Linn damage spatial cognitive behavior in albino mice via up regulation of oxidative stress and acetylcholinesterase

Ekta Yadav and Amita Verma

62

IFNγ controls the monocyte to phagocyte transition during tissue inflammation

Ana Amorim, Dunja Mrdjen , Vinko Tosevski, Melanie Greter, Florent Ginhoux, and Burkhard Becher